Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which h…
Biotechnology
US, Stafford [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Greenwich LifeSciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDGreenwich LifeSciences, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Greenwich LifeSciences, Inc..
If you want to see a demo, head over to the financial segments of AAPL